Reply
Arthritis Care Res (Hoboken)
.
2020 Dec;72(12):1828-1829.
doi: 10.1002/acr.24456.
Authors
Maria A Lopez-Olivo
1
,
Gregory Pratt
1
,
Maria E Suarez-Almazor
1
,
Inés Colmegna
2
,
Aliza R Karpes
3
,
Susan Ruyu Qi
4
,
Natalia V Zamora
5
,
Robin Sharma
6
Affiliations
1
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
2
McGill University, Montreal, Quebec, Canada.
3
University of Texas Health Science Center at Houston School of Public Health, Houston, Texas, United States.
4
Université de Montréal, Montreal, Quebec, Canada.
5
Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina.
6
Nassau University Medical Center, East Meadow, New York, United States.
PMID:
32961036
DOI:
10.1002/acr.24456
No abstract available
Publication types
Letter
Comment
MeSH terms
Antirheumatic Agents*
Arthritis, Rheumatoid*
Humans
Neoplasms*
Substances
Antirheumatic Agents